Holoclara

Recent Finacing

Series A

Recent Raise

$16M

Holoclara is a biotechnology company that mines immunomodulatory molecules from gut roundworms and uses synthetic chemistry to develop orally available therapeutics for allergic and autoimmune disorders.

Founded 2017

California, United States

1-10

Private

holoclara.com

Highlights

Focus Areas

Therapeutics

Recent Investors

T

Financials

$16M

Total Raised

1

Funding round

5

Investors

Team

Upgrade to view the team

See the team members at Holoclara.